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Background: Although individual occurrence is rare, syndromic obesity with mental retardation has been reported
in conjunction with 140 different diseases.
Case presentation: The patient was born at term after a pregnancy complicated by threatened miscarriage. A
diagnosis of Bardet-Biedl syndrome (BBS; OMIM #209900) was made in another hospital when she was 8 years old,
but other clinical problems emerged subsequently. She came to our attention for the first time when she was
14 years old. The clinical picture, characterized by the presence of ophtalmological, renal, endocrinological, and liver
disorders associated with a peculiar weight growth pattern, was more suggestive for Alström syndrome (ALMS;
OMIM #203800); consequently, a genetic study was performed. Genetic analysis revealed a novel compound
heterozygous frameshift mutation on exon 8 of ALMS1 (c. [3251_3258delCTGACCAG] and c. [6731delA]), which has
not previously been described.
Conclusion: Early onset of retinal degeneration associated with obesity represents a diagnostic challenge in
paediatric and genetic practice, although the absence of skeletal abnormalities and developmental delay could help
in addressing the clinical diagnosis. Confirmation of clinical suspicion by genetic analysis has been diriment in this
case, since only a single gene is known to cause ALMS.
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Obesity is a highly heritable complex disorder character-
ized by body mass index (BMI) >30 kg/m2 (Kg weight/m2
height) which poses a major threat to public health world-
wide although it is seldom associated with metabolic syn-
dromes [1]. Both isolated and syndromic obesities have
been recognized; the latter are often associated with the
presence of congenital malformations and neurological
diseases (i.e., developmental delay and/or intellectual dis-
ability) [1,2]. Although individual occurrence is rare, syn-
dromic obesity with mental retardation has been reported
in conjunction with 140 different diseases. Some peculiar
features can be found in syndromic obesity, such as retinal
degeneration. This feature is of particular interest for its
clinical relevance, rarity and diagnostic power; only 30* Correspondence: susanna.esposito@unimi.it
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unless otherwise stated.conditions have this association. Among these, Alström
syndrome (ALMS; OMIM #203800) is an autosomal
recessive multi-systemic disorder characterized by cone
rod-dystrophy resulting in blindness in early childhood,
progressive hearing impairment, infantile or adolescent
onset dilated cardiomyopathy, metabolic defects leading to
hyperinsulinemia, hypertriglyceridaemia, type-2-diabetes
mellitus, and obesity [3], and progressive pulmonary,
hepatic and renal dysfunction [4]. Diagnosis is very dif-
ficult in early infancy, due to age-dependent typical fea-
tures, often not evident until 6–8 years (Table 1). The
identification of ALMS as a ciliary protein disorder ex-
plains the range of observed phenotypes and their simi-
larity to other ciliopathies [4] such as Bardet-Biedl
syndrome (BBS; OMIM #209900), a multi-systemic dis-
ease that comprises retinal dystrophy associated to
obesity, polydactyly, renal malformations, hypogonad-
ism, and cognitive impairment [5]. BBS is an autosomal
recessive condition, although an oligogenic mode of in-
heritance has been shown in some families where three
mutations at two BBS loci are found [6,7]. Diagnosistd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Diagnostic criteria for Alström syndrome (modified from Marshall et al., 2007 [4]) and for Bardet-Biedl
syndrome (modified from Beales et al.,1999 [2])
ALMS BBS
Diagnosis is made when the following criteria are present: Diagnosis is made when:
2 major OR 1 major + 2 minor 4 major criteria are present OR
2 major OR 1 major + 3 minor 3 major plus 2 minor criteria are present
2 major + 2 minor criteria OR 1 major + 4 minor criteria
Age Major criteria Minor criteria Major criteria Minor criteria
<2 years ALMS 1 mutation in 1 allele and/or family
history of ALMS
Obesity Rod-cone dystrophy Speech disorder/delay
DCM/CHF Strabismus/cataracts/
astigmatism
Vision (nystagmus, photophobia) Polydactyly Brachydactyly/syndactyly









acuity, cone dystrophy by ERG)
(History of) DCM/CHF Disabilities
Hearing loss Hypogonadism in males Ataxia/poor coordination/
imbalance
Advanced bone age











Vision (legal blindness, history of nystagmus
in infancy/childhood, cone and rode dystrophy
by ERG)
(History of) DCM/CHF Left ventricular
hypertrophy/congenital
heart diseaseHearing loss







DCM/CHF: dilated cardiomyopathy with congestive heart failure; ERG: electroretinogram; DM2: type 2 diabetes mellitus.
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and renal abnormalities. However, because of the in-
constancy of these two features, due to clinical variabil-
ity, and the late onset of other symptoms (i.e. retinal
degeneration, genital abnormalities, and obesity), diag-
nosis is usually given during later childhood.
To date, 18 genes (BBS1-18) are known to be associated
with BBS [8], whereas only one gene has been identified
for ALMS [5,9]. Nevertheless, overlapping phenotypes
have been reported between ALMS and BBS [10-12].
In syndromes with overlapping clinical signs but differ-
ent natural history, major complications and follow-up,
differential diagnosis can be challenging in order to as-
sess a specific management and treatment regimen. In
this paper, we report a patient previously diagnosed with
BBS who was reassessed for a clinical and genetic diag-
nosis of ALMS.Case presentation
Our patient is the only daughter of unrelated healthy par-
ents, and family history was unremarkable for genetic dis-
eases. She was born at term after a pregnancy complicated
by threatened miscarriage. Her birth weight was 3,480 g,
with a birth length of 48.5 cm, occipital frontal circumfer-
ence of 33.5 cm, and APGAR score 9/10. Since the first
months of life, nystagmus and exotropia were noticed, and
a retinopathy with severe low vision (1/20) was subse-
quently diagnosed. Retinal hypopigmentation and periph-
eral atrophy with extension to macular region were
detected in the first years of life, and lack of response was
demonstrated with electroretinogram and visual evoked
potentials. Leber’s congenital amaurosis was initially sus-
pected. In addition, the pattern of growth was always over
2 standard deviations for weight centile. In accordance
with the presence of these features, a diagnosis of BBS was
Figure 1 Growth chart of the patient (four consecutive evaluations since the first visit in our center, BMI respectively 29.6, and after
the beginning of an hypocaloric diet, 26.2, 27.1, 28.4 Kg/m2).
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ever, other clinical problems emerged subsequently. The
ocular anterior segment was initially normal, but a left cor-
tical cataract emerged when the patient was 12 years old.
Moreover, biochemical investigation showed hypertriglyc-
eridemia, high LDL-cholesterol, low HDL-cholesterol, and
increased insulin and C-peptide levels with a normal
value of hemoglobin A1c. Hepatic dysfunction with
hypertransaminasemia and mild cholestasis was further
investigated by ultrasound evaluation that showed liver
steatosis. Mild hypertension and thickening of cardiac
mass were detected shortly after by cardiologic examin-
ation, and mild micro-albuminuria and proteinuria were
discovered by urine analysis. The patient was also treated
for precocious puberty; after the stop of therapy, hirsut-
ism, hyperadrogenism, and later oligoamenorrhoeaFigure 2 Two novel heterozygous frameshift mutations were detecte
sequences relative to the regions on exon 8 in which the deletions (indica
ATG of the coding sequence (c.) of ALMS1 mRNA (NM_015120.4), respectiv
termination codon (*) at the protein sequence level is indicated (p.). Nome
E [13].were detected. She also suffered from scoliosis and re-
strictive pulmonary dysfunction. Additionally, bilateral
sensorineural hearing loss for high frequencies was de-
tected since she was 13 years old. No mental retardation or
any signs of motor or speech delay were ever reported. A
neurological evaluation was only requested for muscle
cramps during adolescence; on that occasion, a suspi-
cion of a mitochondrial disease was formulated due to
the clinical spectrum of signs, but no imbalance of
mitochondrial chain was confirmed.
She came to our attention for the first time when she
was 14 years old. The clinical picture, characterized by the
presence of ophthalmological, renal, endocrinological, and
liver disorders associated with a peculiar weight growth
pattern (Figure 1) was more suggestive of ALMS, and con-
sequently a genetic study was performed. Genomic DNA,d in the proband. Panels show the chromatograms of the forward
ted by the arrows) are located, at positions 3251 and 6731 from the
ely. The position of the frameshift (fs) and of the predicted premature
nclature of mutations is according to den Dunnen JT and Antonarakis
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to standard methods, was amplified using a standard poly-
merase chain reaction (PCR) protocol with HotStarTaq
Master Mix Kit (QIAGEN GmbH, Hilden, Germany).
Primer sequences and amplification conditions are avail-
able on request. PCR amplicons of exons 8, 10 and 16 of
ALMS1 were purified, directly sequenced using ABI
PRISM Big Dye Terminator Cycle sequencing Ready Reac-
tion Kits, and analyzed with an ABI 3100 Sequencing
Analyzer (Applied Biosystems, Forster City, CA, USA).
Resulting sequences were compared with the GenBank
mRNA reference sequence (NM_015120.4) using Clus-
talW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
The nomenclature of mutations was assigned according to
den Dunnen and Antonarakis [13]. Genetic analysis re-
vealed a novel compound heterozygous frameshift muta-
tion on exon 8 of ALMS1 (c. [3251_3258delCTGACCAG]
and c. [6731delA]; Figure 2), which has not been described
previously. Both mutations result in a premature termin-
ation codon and truncation of the protein.
Discussion
The range of biological causes that account for childhood
obesity is heterogeneous, with several reports of multi-
systemic monogenic disorders [14]. Many of these disor-
ders have a peculiar presentation but could have an over-
lapping phenotype, indicating the likelihood of a shared
common underlying pathway. This is well represented by
BBS and ALMS, both classified as “ciliopathies” according
to the aetiology. Clinical overlap between these two en-
tities has been described, although BBS and ALMS are
genetically distinct. In our patient there was no evidence
of poly or syndactyly suggestive for BBS, and retinal dys-
trophy was observed since the first months of life. This
stands in contrast with BBS, where retinal dystrophy is a
nearly constant finding at over 5 years of age [6,10,15].
Moreover, complete blindness usually occurs in the sec-
ond decade of life [16] in ALMS, and bilateral subcapsular
cataracts are also common [17]. In our patient, sensori-
neural hearing loss for high frequencies, a peculiar feature
described in 89% of individuals with ALMS [4], was also
detected. The diagnosis of BBS was questioned by the
presence of early onset retinal degeneration, insulin resist-
ance, the absence of polydactyly, and relative preservation
of cognitive function. Although ALMS may be difficult to
diagnose because of its rarity and age dependent phe-
notype, early detection of the syndrome would allow
clinicians to recognize the progressive development of a
multi-organ pathology that can lead to reduced life ex-
pectancy [16], allowing for the establishment of a specific
follow-up procedure and supportive therapy. In particular,
the development of a heart failure, diabetes mellitus, obes-
ity, liver and renal dysfunction could negatively interact,
and they must be suspected and/or treated early.Conclusions
Early onset retinal degeneration associated with obesity
represents a diagnostic challenge in paediatric and genetic
practice, although the absence of skeletal abnormalities
and developmental delay could facilitate clinical diagnosis.
Careful medical history and clinical examination remain
the cornerstones of diagnosis. Confirmation of clinical
suspicion by genetic analysis has been diriment in this case
since ALMS has been associated with a single causative
gene, implying a faster diagnostic process with a lower
economic impact. Within the last few years, research into
the pathogenesis of ALMS has led to better management
and treatment not only for this condition, but also for
more common ciliopathies. Ultimately, the monogenic
model of ALMS may facilitate the understanding of the
biochemical pathways of more common diseases affecting
the general population, such as obesity, diabetes, or single
organ failure diseases.
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